MetLife Investment Management’s Broadcom AVGO Stock Holding History

MetLife Investment Management’s Portfolio AVGO Stock Details AVGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$401M	Sell	1,294,054 -26,851	-2%	-$8.84M	2.04%	6
2025 Q4	$457M	Sell	1,320,905 -49,896	-4%	-$17.8M	2.21%	6
2025 Q3	$452M	Sell	1,370,801 -36,126	-3%	-$11.1M	2.17%	5
2025 Q2	$388M	Sell	1,406,927 -1,200	-0.1%	-$261K	2.28%	4
2025 Q1	$236M	Sell	1,408,127 -26,446	-2%	-$5.6M	1.27%	9
2024 Q4	$333M	Buy	1,434,573 +18,925	+1%	+$3.5M	1.8%	8
2024 Q3	$244M	Buy	1,415,648 +39,298	+3%	+$6.3M	1.4%	8
2024 Q2	$221M	Buy	1,376,350 +169,370	+14%	+$23.7M	1.31%	9
2024 Q1	$160M	Sell	1,206,980 -34,800	-3%	-$4.31M	1.07%	12
2023 Q4	$139M	Buy	1,241,780 +54,320	+5%	+$5.14M	1%	11
2023 Q3	$98.6M	Sell	1,187,460 -39,180	-3%	-$3.4M	0.77%	17
2023 Q2	$106M	Sell	1,226,640 -4,820	-0.4%	-$344K	0.78%	17
2023 Q1	$79M	Buy	1,231,460 +18,430	+2%	+$1.11M	0.57%	23
2022 Q4	$67.8M	Sell	1,213,030 -21,100	-2%	-$1.06M	0.51%	28
2022 Q3	$54.8M	Sell	1,234,130 -27,580	-2%	-$1.41M	0.46%	30
2022 Q2	$61.3M	Sell	1,261,710 -40,640	-3%	-$2.28M	0.48%	30
2022 Q1	$82M	Buy	1,302,350 +392,900	+43%	+$23.3M	0.53%	23
2021 Q4	$60.5M	Sell	909,450 -17,180	-2%	-$966K	0.5%	24
2021 Q3	$44.9M	Sell	926,630 -20,010	-2%	-$973K	0.4%	38
2021 Q2	$45.1M	Sell	946,640 -26,170	-3%	-$1.21M	0.4%	41
2021 Q1	$45.1M	Sell	972,810 -9,550	-1%	-$442K	0.41%	37
2020 Q4	$43M	Sell	982,360 -37,360	-4%	-$1.46M	0.41%	40
2020 Q3	$37.2M	Sell	1,019,720 -25,890	-2%	-$867K	0.41%	42
2020 Q2	$33M	Buy	1,045,610 +23,140	+2%	+$648K	0.38%	46
2020 Q1	$24.2M	Sell	1,022,470 -31,290	-3%	-$882K	0.33%	59
2019 Q4	$33.3M	Sell	1,053,760 -29,550	-3%	-$897K	0.35%	54
2019 Q3	$29.9M	Sell	1,083,310 -7,800	-0.7%	-$222K	0.33%	58
2019 Q2	$31.4M	Sell	1,091,110 -35,000	-3%	-$1.02M	0.34%	53
2019 Q1	$33.9M	Sell	1,126,110 -56,250	-5%	-$1.52M	0.37%	49
2018 Q4	$30.1M	Sell	1,182,360 -46,080	-4%	-$1.09M	0.37%	48
2018 Q3	$30.3M	Buy	+1,228,440	New	+$27.5M	0.31%	57

Other funds holding AVGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

MetLife Investment Management's AVGO Position: Q1 2026 in Review

MetLife Investment Management reduced its Broadcom (AVGO) stake by 2% in Q1 2026, selling an estimated $8.84M and leaving 1,294,054 shares worth $401M. The position accounts for 2.04% of the portfolio, ranked #6.

MetLife Investment Management first reported a position in AVGO in Q3 2018 and has held it in 31 quarters since. The position peaked at $457M in Q4 2025. 4,662 funds tracked by Wall St. Rank hold AVGO as of Q1 2026.

MetLife Investment Management held 1,294,054 shares of Broadcom worth $401M as of Q1 2026.
MetLife Investment Management sold 26,851 Broadcom shares in Q1 2026, an estimated $8.84M.
Broadcom made up 2.04% of MetLife Investment Management's portfolio in Q1 2026, its #6 holding.
MetLife Investment Management first reported a position in Broadcom in Q3 2018 and has held it in 31 quarters since.
MetLife Investment Management's Broadcom position peaked at $457M in Q4 2025.
4,662 funds tracked by Wall St. Rank held Broadcom as of Q1 2026.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.